APG inhibited the expression of HIF-1α and mediated cell death through the suppression of STAT3 under hypoxia in breast cancer cells, suggesting that APG is a powerful anti-cancer drug to overcome hypoxia-induced chemoresistance [67,68]. This evidence concerns the gene HIF1A and breast cancer.